Emcure Pharmaceuticals Completes Term of Independent Director, Announces Board Changes
Emcure Pharmaceuticals Ltd has announced that Mr. P.S. Jayakumar will cease to be a Director of the company after completing his second consecutive term as an Independent Director. This change is effective from July 21, 2026.The cessation of Mr. Jayakumar as an Independent Director means he will also step down from several key Board Committees. Effective on July 21, 2026, he will no longer serve in the following capacities:
- Chairman of the Audit Committee
- Member of the Nomination and Remuneration Committee
- Member of the Risk Management Committee
The Board of Directors has recorded its appreciation for the contributions provided by Mr. Jayakumar during his tenure as an Independent Director of Emcure Pharmaceuticals Ltd.
EMCURE Stock Price Movement
Emcure Pharmaceuticals Limited gained 4.22% in post-market trading today, settling at ₹1924.5 following a highly positive day for investors. The stock traded to close on a volume of 215,281 shares, coming agonizingly close to its 52-week high of ₹1944.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.